GSTO1 and nonpapillary renal cell carcinoma: Moreover, in ccRCC samples categorized by their pT stage, statistically significant decrease of GSTO1 expression in the late-stage compared to early-stage of disease was found (p = 0.044, Figure 2c, Figure S1, Table S1).